Clinical Report: Epigenetic Factors in Bipolar Disorder: A Bibliometric Overview

Overview

This bibliometric study analyzes the evolving landscape of epigenetic research in bipolar disorder (BD), highlighting significant trends and influential contributors. Key findings indicate a shift towards understanding dynamic regulatory networks and potential biomarkers for BD.

Background

Bipolar disorder is a chronic psychiatric condition with a global prevalence of 1.5% to 2.4%, significantly impacting public health. The role of epigenetics in BD pathogenesis is gaining attention, as it may reveal novel biomarkers and therapeutic targets. Understanding these mechanisms is crucial for advancing clinical care and treatment strategies.

Data Highlights

Key Findings

• The United States is the most productive country in epigenetic BD research.
• Harvard University is identified as the leading institution in this field.
• Kato T is the most prolific author, while Nöthen MM is the most highly co-cited scientist.
• Molecular Psychiatry has the highest publication volume and citation frequency.
• Current research focuses on histone modifications, HDAC inhibitors, and long noncoding RNAs.
• There is a notable interplay between genetic variants and epigenetic regulation in BD.

Clinical Implications

The findings underscore the importance of epigenetic mechanisms in understanding bipolar disorder, which may lead to the identification of novel biomarkers for diagnosis and treatment. Clinicians should remain informed about the evolving research landscape to integrate potential epigenetic insights into future therapeutic strategies.

Conclusion

This bibliometric overview highlights the significant advancements in epigenetic research related to bipolar disorder, emphasizing the need for continued exploration of these mechanisms to enhance clinical outcomes.

Related Resources & Content

1. Frontiers in Psychiatry, 2026 -- Revisiting the prevalence of bipolar disorder: implications of a broader spectrum model
2. BMC Psychiatry (Springer), 2025 -- Investigating seasonal metabolic variations in bipolar disorder: a targeted metabolomics study
3. Frontiers in Neurology, 2026 -- Bipolar disorder and subsequent Parkinson's disease: a meta-analysis of cohort studies
4. VA DoD CPG for Management of Bipolar Disorder
5. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence | Focus
6. Overview | Bipolar disorder: assessment and management | Guidance | NICE
7. BMC Psychiatry (Springer) — Neuroendocrine abnormalities as predictors of suicidal ideation in bipolar disorder patients during depressive episodes: a cross-sectional study
8. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging
9. VA DoD CPG for Management of Bipolar Disorder
10. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence | Focus
11. Overview | Bipolar disorder: assessment and management | Guidance | NICE
12. www.nature.com/tp
13. A perspective on epigenomic aging processes in the human brain and their plasticity in patients with mental disorders – a systematic review | Neurogenetics | Springer Nature Link
14. Evaluating Oxidative Stress Markers in At-Risk Individuals for Bipolar Disorder: A Systematic Review and Meta-Analysis - PubMed
15. Epigenetic Neuropharmacology: Drugs Affecting the Epigenome in the Brain - PMC